To gain m ore insight into the role o f cyto kines in Pneumocystis carinii pneum onia (PCP) we followed pro-inflammatory cytokine profiles in rats with steroid-induced PCP at 2-w eek intervals. The cyto kines m easured were im m unoreactive interleukin-1 (3 (ILriP), bioactive interleukin-6 (ILr6), and tumor n e crosis factor a (TNF-a). In vivo cytokine concentra tions were determ ined in three com partm ents, i.e., bronchoalveolar lavage (BAL) fluid, lung hom ogenates, and plasma. Upopolysaccharide (LPS) -stimulated cyto kine production by alveolar cells and in w hole-blood cultures was m easured ex vivo, P carinii load and host inflammatory response, as determ ined by lung/body weight ratio and 111indium-IgG bio distribution were m onitored throughout developing PCP. IL-1|3 was el evated in lung hom ogenates (6 0 0 , range < 2 0 -1 2 6 0 pg/mL) and IL-6 in BAL fluid (4 8 , range < 2 0 -115 pg/m L), whereas the pro-inflammatory cytokine con centrations were n ot increased in plasm a. Thus in rats with PCP elevated pro-inflammatory cytokine concen trations were found to b e restricted to the lung com partments. Corticosteroids did not significantly influ en ce cytokine concentrations, but showed profound inhibitory effects on ex vivo cytokine production. The LPS-stimulated cytokine production by alveolar cells gradually decreased during the 6 w eeks after the start o f the steroid injections, whereas the production in whole blood cultures was im m ediately and com pletely suppressed. J. Leukoc. BioL 6 0 : 7 1 0 -715; 1 9 9 6 . K ey Wbrds: corticosteroids • interleukin-1 * interleukin-6 * tumor necrosis factor a • ulIn-IgG biodistribution * bronchoalveolar la vage ■ lung homogenates
studies show that P. carinii possesses binding sites for tumor necrosis factor a (TNF-a) and that this cytokine is capable of killing P. carinii [3] [4] [5] . In mice TNF-a and interleukin-1 p (IL-1P) are critical in the clearance of P. ca rinii and interleukin-6 (IL-6) was found to regulate pulmo nary inflammation and antibody response during resolu tion of PCP [6] [7] [8] . P, carinii has been reported to stimulate in vivo and in vitro production of TNF-a by alveolar macro phages [9] [10] [11] [12] [13] [14] .
Corticosteroids down-regulate pro-inflammatory cyto kine production and increase the risk for PCP in patients and in animal models [15] [16] [17] [18] . We previously described cytokine patterns in immunosuppressed HIV seronegative and HIV seropositive patients with PCP [19, 20] . In these studies corticosteroids did not seem to influence plasma cytokine concentrations but we observed strong downregulation of cytokine production in whole blood cultures of patients with severe PCP who had been given cortico steroids. However, since severe infection in itself can also down-regulate pro-inflammatory cytokine production, it was impossible to assess the relative contribution of corti costeroids and P. carinii pneumonia to the measured cyto kine profiles [21, 22] . This prompted us to perform cytokine studies in immu nosuppressed rats infected with P. carinii under carefully controlled experimental conditions.
INTRODUCTION
Pneumocystis carinii pneumonia (PCP) is a common patho gen in immunocompromised hosts. Cellular immunity, in particular CD4+ lymphocyte-dependent mechanisms, are considered important host defense mechanisms against Pneumocystis carinii [1, 2] -Evidence to date indicates that cytokines, the intercellular messengers involved in many inflammatory processes, also play a role in PCP In vitro ous injections of 25 mg hydrocortisone and an 8% protein-restricted diet. Amoxicillin (1 mg/mL) was added to the drinking water to prevent bacterial infections. PCP was induced by close cohabitation with P. carimi-infected rats (PCP rats), thereby exposing them passively to Ft cariniU which is transmitted by air. Similar to other investigators, we lost 1 5 -2 5 % of the rats before endpoints were reached [23] . Of the rats who survived 4 weeks of cohabitation with infected littermates, m ore than 95% developed PCP. As we have shown before, the second ary rats develop a consistent and com parable PCP and the level of in fection is standardized by the P. carinii density score (see below). B arrier-sustained rats (housed at another level of the animal quarters in cages covered with air filters) were subjected to the same immuno suppressive regime without development of PCP (steroid rats). Control rats were not im m unosuppressed, were barrier-sustained, and were free of PC P (healthy rats). Viral co-infection was excluded by regular serological screening for common rodent viruses. Bacterial or fungal coinfection was excluded by microscopic examination of Giemsa-stained sm ears of the cut surface of the lung. Body weight was measured weekly.
At 2-w eek intervals after the start of the immunosuppression, J11indium -IgG (^In -Ig G ) was given intravenously to a group of PCP, stero id , and healthy rats as described elsewhere [23] . Two days later th e anim als were killed by bleeding and a bronchoalveolar lavage (BAL) w as perform ed [24] . Total lung weight before the BAL and w eights o f the separate lung lobes after BAL were measured. The up ta k e of ^I n -I g G was m easured in the right upper lung iobe and in a n o rm al calf muscle sample for reference. P. carinii density was as se sse d in Giem sa an d silver-stained impression smears and expressed in the logarithm ic P. carinii density score as described by Bartlett [16] . Tw o individuals who were blinded to the condition of the animals ex a m in e d th e slides and rated them according to the following score: in o n e 1 0 0 0 X field > 100 cysts = 5, 1 1 -1 0 0 = 4, 1 -1 0 = 3, 2 -9 in 10 1 0 0 0 X fields = 2, 1 in 10 fields = 1, and 0 in 50 fields ~ 0.
Processing BAL fluid and lung tissue
Im m ed iately after BAL the fluid was centrifuged at 500 g fo r 15 min. S u p e rn a ta n t was rem oved, aliquoted, and frozen at -8 0°C. The pellet w as resu sp en d ed in Dulbecco's modified Eagle's medium at a concen tratio n o f 0 .5 X 1 0 6 viable macrophages/mL; viability was assessed by try p a n b lu e dye exclusion. This was subsequently incubated in 2-mL c lo se d polystyrene tubes (Greiner, Alphen, The Netherlands) in the p re s e n c e or absence of lipopolysaccharide (LPS; Escherichia coli sero ty p e 0 5 5 :B 5, Sigma) at a final concentration of 10 (ig/mL. All incuba tio n s w ere done at 3 7°C for 24 h in a CO2 incubator. Following incu b a tio n th e tubes were centrifuged at 1200 g for 10 min and the s u p e rn a ta n t and cell pellets separately frozen at -8 0°C until cytokine an aly sis. T he left upper lung lobe was homogenized in a blender and s o n ic a te d in a 10-m L phosphate-buffered saline (PBS) solution of pro te a s e inhibitors containing 2 mmol phenylmethylsulfonyl fluoride, 1 m g /L an tip ain , 1 mg/L aprotinin, 1 mg/L leupeptin, and 1 mg/L pepstatin . T h e sonicated homogenate was centrifuged at 1200 gfor 15 min a n d the su p ern atan t frozen until cytokine analysis.
Processing whole blood
B lood w as collected aseptically into three 2-mL polystyrene tubes con tain in g 2 0 p,L heparin (heparin sodium 5000 IU/mL, LEO Pharma-ceuLicals BV, W eesp, The Netherlands). One tube was immediately c e n trifu g e d at 1 2 5 0 g fo r 10 min; the plasma was transferred to a poly p ro p y le n e tube and frozen at -8 0°C until cytokine analysis. To one o f the two rem aining tubes LPS was added (final concentration 10 jlg /m L ) to stim ulate cytokine production. This tube and the third tube w ere in cu b ated at 3 7°C for 2 4 h. After incubation the tubes were cen trifu g ed and the supernatant frozen at -8 0°C .
Cytokine assays
P lasm a an d BAL sam ples were analyzed by means of bioassays for IL-6 a n d T N F -a, respectively, and enzyme-linked immunosorbent assay (ELISA) for IL -ip . IL-6 was m easured by use of the B9 hybridoma bio assay; T N F-a was m easured by the L929 cytotoxicity assay [25, 26] . For IL-1 we used a specific rat ELISA (provided by Dr. S. Poole, Na tional Institute of Biological Standards, Hertfordshire, UK). The detec tion limit of all three assays was 20 pg/mL,
Radiopharmaceutical protocol
u l In-lgG scans and biodistribution are sensitive an d quantitative m eth ods to assess the severity of PCP [23, 27, 28] . n i In-IgG enters inflam matory sites via increased vascular permeability, after which the indium is split off from the IgG and remains at that site. W e have shown in an earlier report that 111 In accumulation in the lung correlates well with P, carinii density scores and parameters of host inflammatory re sponses [23] . IgG diethylene triamine penta-acetic bicyclic anhydride was conjugated to hum an, nonspecific, polyclonal IgG (Sandoglobulin, Sandoz AG, N eurenberg, FRG) according to the method described by Hnatowich and colleagues [29] . The conjugated solution was radiolabeled with l u In (indium chloride, Mallinckrodt Medical, Petten, The Netherlands) via citrate transchelation. Radiochem ical purity was determ ined by ITLC-SG chromatography (Gelman Laboratories, Ann Arbor, MI) with 0.1 M citrate (pH 5) as the solvent. Labeling efficiency was always > 95% .
For biodistribution studies, lung and muscle activity were m easured 48 h after injection of 1 0 p,g IgG labeled with 1 MBq ^I n by count ing the tissue sam ples in a shielded well-type gam m a counter. To cor rect for radioactive decay and permit calculation of the uptake of the radiopharm aceuticals in each organ as a fraction of the injected dose, aliquots of the respective dose were counted sim ultaneously. The activ ity m easured in tissues was expressed as percentage of injected dose per gram. Lung-to-muscle ratios were calculated.
Statistics
Data on P. carinii density score, lung-to-body weight ratio, and 111 In-IgG uptake, were normally distributed and are therefore given in m eans and standard error ( s e ) and analyzed by Students's i-test. Cytokine con centrations and production did not follow Gaussian distributions and are therefore given in m edians and ranges and analyzed with the nonparam etric M ann-W hitney test. Lung-to-body weight ratios, 1]1In-IgG uptake, and the various cytokine concentrations an d production capac ities were evaluated as param eters for inflammation using a one-way analysis of variance (ANOVA), including a Bonferonni correction to com pensate for m ultigroup testing. Linear regression coefficients w ere calculated.
The study was approved by ihe University Committee on Animal Experiments.
RESULTS 4
Development of PCP and host inflammatory responses' P. carinii density in lungs of rats exposed to P. cariniiinfected littermates steadily increased during the 6 weeks after the start of immunosuppression (Fig. 1A) . Similarly, host inflammatory reaction, expressed in terms of lungto-body weight (L/B) ratio ( Fig. IB) and u l In-IgG lung-tomuscle biodistribution (L/M ratio, Fig. 1C ) increased every 2 weeks. Both ratios were correlated with the P. carinii density score (r = 0.8, P < 0.0001).
Although the L/B ratio of steroid rats also slightly in creased over time, the ratio was always higher in PCP rats. L/M ratios in PCP rats were significantly higher than in ste roid rats or healthy rats at weeks 4 and 6. 
Cytokine concentrations in BAL and lung homogenates
Immunoreactive IL-1(3 was present in BAL fluid of healthy rats at a concentration of 280 pg/mL (range <20-640 pg/mL; Fig. 2A ). The median IL-13 concentrations in BAL in steroid and PCP rats were lower, these differences were, however, not significant. In lung homogenates of PCP rats IL-iP concentrations at weeks 4 and 6 were significantly higher than in steroid or healthy rats (week 6: 600, range <20-1260 vs. 43, range 2 7 -3 2 0 , respectively, <20, range <20-380 pg/mL, P < 0.05; Fig. 2B ).
Bio active IL-6 could not be detected in BAL fluid of healthy rats or immunosuppressed rats. However, IL-6 was found in BAL fluid of rats with PCP at week 4 and 6, with the highest concentration at week 4 (Fig. 2C ). Although these IL-6 concentrations were relatively low (48, range <20-115 pg/mL), the differences with healthy and steroid rats were significant (P < 0.05). IL-6 could not be found in lung homogenates of rats in any of these groups. Bio active TNF-a could not be detected in BAL fluid or lung homogenates of rats in any group. 4 IL-6 was present in plasma (21-136 pg/mL) from 6 of the 19 immunosuppressed rats in week 4 and 6 irrespective of the presence of PCP. Although IL-6 could not be de tected in the plasma of healthy rats, the differences be tween PCP and healthy rats were not significant. Bioactive TNF-a and immunoreactive IL-1(3 could not be detected in the plasma of the rats in any group.
Cytokine concentrations in plasma

Ex vivo cytokine production by alveolar cells
LPS-stimulated production of IL-1 [3, IL-6, and TNF-a gradually decreased over the 6-week period in both steroid and PCP rats, with a slower decline in PCP rats ( Fig. 3) .
At week 4 the production of pro-inflammatory cytokines was higher in PCP than in steroid rats, although this differ ence was only significant for IL-6. In the absence of LPS, ex vivo cytokine production of alveolar cells was generally low (<400 pg/mL); however, in week 4 significant amounts of IL-6 (747, range 20-2650 pg/mL) and TNF-a (545, range < 2 0 -2 4 0 0 pg/mL) secretion was. found in the non stimulated culture supernatant in PCP rats.
Ex vivo production in whole-blood cultures
In healthy rats, LPS-stimulated production of IL-1 (3 was 500, range 2 0 0 -7 8 6 pg/mL and of IL-6 2250, range 600-5000 pg/mL. Both in PCP and steroid rats IL-1 P and IL-6 production was almost completely suppressed from week 2 onward (Fig. 3, D and E) .
In the absence of LPS ex vivo production of proinflammatory cytokines was around the detection limit, with an exception for IL-6 in steroid rats at weeks 4 and 
Correlations between cytokine patterns and parameters of inflammation
Cytokine concentrations in BAL, lung homogenates, of plasma did not correlate with the other inflammatory pa rameters. The LPS-stimulated production of TNF-a and IL-6 by alveolar cells in steroid rats was inversely corre lated with L/B ratios (.r = -0.63, P = 0.01, respectively, r = -0 .7 2 , P = 0.002). There was no correlation with L/M ratios. The LPS-stimulated production of IL-6 by al veolar cells in PCP rats was inversely correlated with L/B ratios (r = -0.58, P = 0.02) as well as with L/M ratios (r = -0.61, P = 0.01). Production in whole-blood cul tures did not correlate with other inflammatory parameters. In this study on experimental PCP in rats, pro-inflamma tory cytokine concentrations were followed in BAL fluid, lung homogenates, and plasma and were compared with those in rats subjected to the same immunosuppressive regime but without PCP (steroid rats) and with those of healthy rats. In rats with PCP, elevated pro-inflammatory cytokine concentrations were found in the lung compart ments at weeks 4 and 6* i.e., IL-1(3 in lung homogerxates and IL-6 in BAL fluid. Why different pro-inflammatory cytokines are present in the different lung compartments requires further study. The explanation is most likely multifactorial and may reflect relative differences in cytokineproducing cell populations, presence of other inflamma tory proteins, and presence or absence of surfactant in the different lung compartments. The presence of pro-inflam matory cytokine concentrations in the lung is supported by the results obtained with ex vivo production of cytokines. At week 4, when the infection is clearly established and all PCP rats have elevated P. carinii density scores, alve olar cells of PCP rats spontaneously produced substantial amounts of IL-1(3 and IL-6 and their LPS-stimulated pro duction was higher than in steroid rats. This could point to activation of these cells in vivo. Previously we observed a similar pattern in patients with PCP, showing increased pro-inflammatory cytokine concentrations in BAL fluid [19, 20] . In HIV-seronegative/PCP-positive patients on long term corticosteroids, immunoreactive TNF-a was found to be increased in BAL fluid, whereas in HIV-seropositive pa tients IL-1JJ was found to be increased. In this study on rat PCP, we used a TNF-a bioassay and the undetectable concentrations of TNF-a in BAL and lung homogenates may be due to the presence of inhibitors, such as soluble TNF-a receptors. A reliable immunoassay for rat-TNF-a was not available to us.
Our finding of undetectable bioactive TNF-a levels in whole-blood cultures, even following LPS stimulation, 6 (150, range < 2 0 -3 6 5 pg/mL, respectively, 340, range differs from the findings of Wright et al. [30] . Differences in animal model (rabbit vs. rat) and bioassay (WEHI vs, L929 bioassay) may explain the discrepancy.
Similar to our data in humans with PCP, plasma con- centrations of pro-inflammatory cytokines were not ele vated in PCP rats, pointing to a compartmentalization of the pro-inflammatory cytokines in the lungs. One may spec ulate that the pro-inflammatory cytokines are needed in the lung to neutralize P. carinii, whereas the body should be protected from the deleterious effects of pro-inflamma tory cytokines in the circulation. Apparently the effect of steroids on systemic and local cytokine concentrations are limited, as these concentra tions were not significandy different between healthy and steroid rats. These findings are consistent with our data in patients with PCP, which showed that cytokine concentra tions did not differ between steroid-treated and non steroid-treated patients [19, 20] .
The ex vivo production, however, was profoundly influ enced by corticosteroids administered in vivo. LPSstimulated pro-inflammatory cytokine production by alve olar cells in both PCP rats and steroid rats was not imme diately suppressed, since it took 6 weeks before complete suppression was reached. These findings refute the sugges tion of Huang et al. that the beneficial effect of steroids on the clinical course of PCP is due to immediate suppres sion of the pro-inflammatory cytokine production by alve olar cells [31] .
Although ex vivo cytokine production in whole blood cul tures was also influenced by corticosteroids, the time course was different; in these cultures the cytokine produc tion was immediately and profoundly suppressed. No pro duction could be elicited at week 2, whereas a slight re covery was seen at weeks 4 and 6. This pattern was similar in PCP and steroid rats, suggesting a profound influence of steroids on the systemic cytokine response.
The differential effect of steroids on cytokine produc tion in alveolar cells and blood is in agreement with the findings in patients with PCP. In steroid-treated HIVseropositive patients with PCP, production of immunoreac tive IL-6 and TNF-a in whole-blood cultures was sup pressed while the production in alveolar cells was not affected [20] . It also accords with the in vitro findings of Strieter et aL, who showed that the effects of steroids on TNF-a production were more pronounced in peripheral blood monocytes than in alveolar macrophages [32] . In PCP in rats, the relative u l In-IgG uptake in the lung (L/M ratio) seems to be a better parameter of inflammation than the relative body, weight, as it discriminates better be tween steroid-treated rats with and without PCP and hardly differs between healthy and uninfected steroid rats.
Although concentrations of IL-6 and IL-1 (3 were ele vated in weeks 4 and 6, when there was established PCP, they did not correlate with the other inflammatory param eters, L/B and 1}1In-IgG L/M ratios. This was similar to our findings in patients, showing no correlation between cytokine concentrations and clinical severity of the disease [19, 20] .
Despite some differences, the steroid-induced PCP in the rat is a good model for human steroid-induced PCP an d suitable to study the effect of cytokine modulation on the course of PCP.
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